Eden Bernstein
@edenbernstein.bsky.social
Hospitalist and alcohol use disorder researcher @cudivhospmed.bsky.social
🚨 Which interventions actually help improve post hospital treatment engagement for alcohol use disorder? Check out our new systematic review in Annals 👇
Annals of Internal Medicine@annalsofim.bsky.social · 3d agoNEW: A systematic review found that hospital-based interventions to improve outpatient follow-up for alcohol use disorder (AUD) after discharge show mixed results. https://bit.ly/4zHkh2i
Let's talk Medications for Alcohol Use Disorder (MAUD). Are we initiating and discharging patients with MAUD adequately? Are we using the full available arsenal of meds? Read the full paper! 🔗 https://doi.org/10.1002/jhm.70201 ✍️ Eden Bernstein, MD MPH et al 🖼️ Iuliia Kovalenko, MD
In a new study, we found that one in ten US adults have overlapping risky alcohol use and obesity with implications for the use of GLP-1’s to mitigate these liver disease risk factors 👇
Heavy Drinking, Alcohol Use Disorder, and Obesity
This cross-sectional study examines the prevalence of co-occurring alcohol use and obesity conditions among US adults by sex, age, race and ethnicity, and other factors.
jamanetwork.com
Check out our new editorial for the latest on evidence for GLP-1’s for the treatment on alcohol use disorder
Distilling the evidence for GLP-1 receptor agonists in alcohol use disorder - Addiction Science & Clinical Practice
Addiction Science & Clinical Practice -
link.springer.com
In our national study of hospitalizations from 2016-2022, we describe overall stable rates of alcohol-related hospitalizations but increasing inpatient mortality, length of stay, patient complexity, and cost. Just published in @jamanetworkopen.com👇
Alcohol-Related Hospitalizations From 2016 to 2022
This cross-sectional study examines US trends in the rate and outcomes of alcohol-related hospitalization from 2016 to 2022 using data from the National Inpatient Sample.
jamanetwork.com
🚨Our new paper in @jhospmedicine.bsky.social describes large hospital-level variation in initiation of medications for alcohol use disorder during alcohol withdrawal hospitalizations. Huge opportunity for increasing uptake of evidence based treatment! @cudivhospmed.bsky.social
Variation in initiation of medications for alcohol use disorder during alcohol withdrawal hospitalizations in a large health system: A retrospective cohort study
Background Alcohol withdrawal hospitalizations present unmet opportunities to initiate medications for alcohol use disorder (MAUD). Objective To examine patient and hospital factors associated wit...
shmpublications.onlinelibrary.wiley.com
Nearly one in 10 people with substance use disorders are hospitalized in a year, yet disorder treatment often isn’t available, says a new study by @cudeptofmedicine.bsky.social faculty @edenbernstein.bsky.social, Gina Kruse, MD, and Susan Calcaterra, MD, MPH. @cuanschutz.bsky.social #cucityofhealth
Hospitalization Is a ‘Missed Opportunity’ to Treat Substance Use Disorder
A study by CU Department of Medicine faculty shows nearly one in 10 people with SUDs are hospitalized in a year, yet disorder treatment often isn’t available.
news.cuanschutz.edu
Excellent trial comparing oral vs injectable naltrexone at hospital discharge 👇
Oral vs Extended-Release Injectable Naltrexone for Hospitalized Patients With Alcohol Use Disorder
This randomized clinical trial compares the effectiveness of initiating oral naltrexone vs extended-release injectable naltrexone on reduction in alcohol use and health care utilization among medical ...
jamanetwork.com
Hospitalizations present unmet opportunities for addiction treatment engagement. Our new paper in @annalsofim.bsky.social describes the prevalence of hospitalizations among adults with substance use disorders to inform the reach of hospital-based addiction treatment programs🧵
Prevalence of Hospitalizations Among a National Sample of U.S. Adults With Substance Use Disorders | Annals of Internal Medicine
acpjournals.org
👋 #Medsky Check out our new paper on differences in post-hospitalization outcomes between Medicare Advantage and traditional Medicare beneficiaries with alcohol withdrawal and opioid overdose
Association of Medicare Advantage vs Traditional Medicare with Clinical Outcomes Among Patients Hospitalized for Substance Use Disorders - Journal of General Internal Medicine
Background Medicare Advantage (MA) includes incentives to reduce health care spending and insures over half of Medicare eligible adults. Substance use disorders (SUD) are common in this population. Ob...
link.springer.com
1. Today the NIH director issued a new directive slashing overhead rates to 15%. I want to provide some context on what that means and why it matters. grants.nih.gov/grants/guide...
NOT-OD-25-068: Supplemental Guidance to the 2024 NIH Grants Policy Statement: Indirect Cost Rates
NIH Funding Opportunities and Notices in the NIH Guide for Grants and Contracts: Supplemental Guidance to the 2024 NIH Grants Policy Statement: Indirect Cost Rates NOT-OD-25-068. OD
grants.nih.gov
New @thelancet.bsky.social Editorial - American chaos: standing up for health and medicine www.thelancet.com/journals/lan... #MedSky #GastroSky
Excited to share our perspective in @nejm.org led by @trishasantos.bsky.social & @fabioethics.bsky.social Texas GA-46 threatens confidentiality and trust between clinicians and immigrants. We must advocate to protect privacy and ensure hospitals remain safe spaces.
Trisha Santos, MD, MS@trishasantos.bsky.social · 2y ago📢 Clinicians must continue to advocate against policies like GA-46 that risk moral injury & conflict with our ethical responsibility to do no harm. Together we can uphold dignity in healthcare. 🙏🏻Grateful to coauthors @cervantes-lily1.bsky.social & @fabioethics.bsky.social tinyurl.com/38fy6dys
Great to chat with @markharden.bsky.social about the link between alcohol and cancer in light of the recent surgeon general advisory!
Mark Harden@markharden.bsky.social · 2y agoThe surgeon general's call for a new warning about alcohol’s links to cancer is the latest effort to raise awareness about a health issue that most Americans aren’t aware of. @cucancercenter.bsky.social and @cudeptofmedicine.bsky.social experts way in. #cucityofhealth @cuanschutz.bsky.social
Great summary of evidence for safety of naltrexone in liver disease 👇
Things We Do for No Reason™: Avoiding naltrexone for alcohol use disorder in liver disease
Hospitalizations related to alcohol use disorder (AUD) are common. Yet, few patients receive pharmacotherapy consistent with guideline recommendations. Previous concerns over the potential hepatotoxi...
shmpublications.onlinelibrary.wiley.com
🚨1 in 3 patients admitted to a VA with #AlcoholUseDisorder die in 5 yrs, with disproportionally high admissions in rural areas. Study by #Hospitalist Dr James Willey reinforces need for urgent action to address AUD in the veteran population. shmpublications.onlinelibrary.wiley.com/doi/full/10....
Impact of alcohol use disorder on inpatient hospitalizations: A comparison of outcomes between urban and rural Veterans Affairs hospitals
Background Alcohol use disorder (AUD) is a leading cause of morbidity and mortality that disproportionately affects rural residents and Veterans. Objective To evaluate the burden of AUD in admissi...
shmpublications.onlinelibrary.wiley.com
